PubMed:10455130
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 14-20 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
| T2 | 478-484 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
| T3 | 531-537 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
| T4 | 791-795 | Glycan_Motif | denotes | SM-3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G20044TD |
| T5 | 1080-1094 | Glycan_Motif | denotes | sialyl Lewis x | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T6 | 1087-1094 | Glycan_Motif | denotes | Lewis x | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00051MO |
| T8 | 1303-1307 | Glycan_Motif | denotes | SM-3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G20044TD |
| T9 | 1362-1373 | Glycan_Motif | denotes | sialic acid | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
| T10 | 1420-1426 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-165 | Sentence | denotes | Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. |
| T2 | 166-342 | Sentence | denotes | Many tumor-associated epitopes possess carbohydrate as a key component, and thus changes in the activity of glycosyltransferases could play a role in generating these epitopes. |
| T3 | 343-576 | Sentence | denotes | In this report we describe the stable transfection of a human pancreatic adenocarcinoma cell line, Panc1-MUC1, with the cDNA for mucin core 2 GlcNAc-transferase (C2GnT), which creates the core 2 beta-1,6 branch in mucin-type glycans. |
| T4 | 577-662 | Sentence | denotes | These cells lack endogenous C2GnT activity but express a recombinant human MUC1 cDNA. |
| T5 | 663-839 | Sentence | denotes | C2GnT-transfected clones expressing different levels of C2GnT were characterized using monoclonal antibodies CC49, CSLEX-1, and SM-3, which recognize tumor-associated epitopes. |
| T6 | 840-1017 | Sentence | denotes | Increased C2GnT expression led to greatly diminished expression of the CC49 epitope, which we identified as NeuAcalpha2,6(Galbeta1,3)GalNAcalpha-Ser/Thr in the Panc1-MUC1 cells. |
| T7 | 1018-1172 | Sentence | denotes | This was accompanied by the emergence of the CSLEX-1 epitope, sialyl Lewis x (NeuAcalpha2,3Galbeta1,4(Fucalpha1,3)GlcNAc-R), an important selectin ligand. |
| T8 | 1173-1248 | Sentence | denotes | Despite this, however, the C2GnT transfectants could not bind to selectins. |
| T9 | 1249-1456 | Sentence | denotes | Increased C2GnT expression also led to masking of the SM-3 peptide epitope, which persisted after the removal of sialic acid, further suggesting greater complexity of the core 2-associated O-glycans on MUC1. |
| T10 | 1457-1586 | Sentence | denotes | The results of this study suggest that C2GnT could play a regulatory role in the expression of certain tumor-associated epitopes. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 791-795 | https://glytoucan.org/Structures/Glycans/G20044TD | denotes | SM-3 |
| T2 | 1080-1094 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sialyl Lewis x |
| T3 | 1087-1094 | https://glytoucan.org/Structures/Glycans/G00051MO | denotes | Lewis x |
| T4 | 1087-1094 | https://glytoucan.org/Structures/Glycans/G01187XC | denotes | Lewis x |
| T5 | 1303-1307 | https://glytoucan.org/Structures/Glycans/G20044TD | denotes | SM-3 |
| T6 | 1362-1373 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 772-776 | http://www.glycoepitope.jp/epitopes/AN0086 | denotes | CC49 |
| T2 | 911-915 | http://www.glycoepitope.jp/epitopes/AN0086 | denotes | CC49 |
| T3 | 1080-1094 | http://www.glycoepitope.jp/epitopes/EP0012 | denotes | sialyl Lewis x |
| T4 | 1087-1094 | http://www.glycoepitope.jp/epitopes/EP0011 | denotes | Lewis x |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 171-176 | HP_0002664 | denotes | tumor |
| T2 | 405-430 | HP_0006725 | denotes | pancreatic adenocarcinoma |
| T3 | 813-818 | HP_0002664 | denotes | tumor |
| T4 | 1560-1565 | HP_0002664 | denotes | tumor |
NGLY1-deficiency
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-NGLY1-deficiency-B_T1 | 485-491 | chem:24139 | denotes | GlcNAc |
| PD-NGLY1-deficiency-B_T2 | 1132-1138 | chem:24139 | denotes | GlcNAc |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 10455130-0#21#61#gene2650 | 21-61 | gene2650 | denotes | beta-1,6-N-acetylglucosaminyltransferase |
| 10455130-0#21#61#gene140687 | 21-61 | gene140687 | denotes | beta-1,6-N-acetylglucosaminyltransferase |
| 10455130-0#73#90#diseaseC0235974 | 73-90 | diseaseC0235974 | denotes | pancreatic cancer |
| 10455130-0#73#90#diseaseC0346647 | 73-90 | diseaseC0346647 | denotes | pancreatic cancer |
| 10455130-0#73#90#diseaseC0235974 | 73-90 | diseaseC0235974 | denotes | pancreatic cancer |
| 10455130-0#73#90#diseaseC0346647 | 73-90 | diseaseC0346647 | denotes | pancreatic cancer |
| 21#61#gene265073#90#diseaseC0235974 | 10455130-0#21#61#gene2650 | 10455130-0#73#90#diseaseC0235974 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene265073#90#diseaseC0346647 | 10455130-0#21#61#gene2650 | 10455130-0#73#90#diseaseC0346647 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene265073#90#diseaseC0235974 | 10455130-0#21#61#gene2650 | 10455130-0#73#90#diseaseC0235974 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene265073#90#diseaseC0346647 | 10455130-0#21#61#gene2650 | 10455130-0#73#90#diseaseC0346647 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene14068773#90#diseaseC0235974 | 10455130-0#21#61#gene140687 | 10455130-0#73#90#diseaseC0235974 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene14068773#90#diseaseC0346647 | 10455130-0#21#61#gene140687 | 10455130-0#73#90#diseaseC0346647 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene14068773#90#diseaseC0235974 | 10455130-0#21#61#gene140687 | 10455130-0#73#90#diseaseC0235974 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| 21#61#gene14068773#90#diseaseC0346647 | 10455130-0#21#61#gene140687 | 10455130-0#73#90#diseaseC0346647 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 21-61 | gene:140687 | denotes | beta-1,6-N-acetylglucosaminyltransferase |
| T1 | 73-90 | disease:C0235974 | denotes | pancreatic cancer |
| T2 | 21-61 | gene:140687 | denotes | beta-1,6-N-acetylglucosaminyltransferase |
| T3 | 73-90 | disease:C0346647 | denotes | pancreatic cancer |
| T4 | 21-61 | gene:2650 | denotes | beta-1,6-N-acetylglucosaminyltransferase |
| T5 | 73-90 | disease:C0235974 | denotes | pancreatic cancer |
| T6 | 21-61 | gene:2650 | denotes | beta-1,6-N-acetylglucosaminyltransferase |
| T7 | 73-90 | disease:C0346647 | denotes | pancreatic cancer |
| R1 | T0 | T1 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| R2 | T2 | T3 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| R3 | T4 | T5 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
| R4 | T6 | T7 | associated_with | "beta-1,6-N-acetylglucosaminyltransferase",pancreatic cancer |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 14-20 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T2 | 478-484 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T3 | 531-537 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T4 | 791-795 | Glycan | denotes | SM-3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G20044TD |
| T5 | 1080-1094 | Glycan | denotes | sialyl Lewis x | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO |
| T6 | 1303-1307 | Glycan | denotes | SM-3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G20044TD |
| T7 | 1420-1426 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 73-90 | Disease | denotes | pancreatic cancer | http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831 |
| T3 | 139-144 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T4 | 171-176 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T5 | 405-430 | Disease | denotes | pancreatic adenocarcinoma | http://purl.obolibrary.org/obo/MONDO_0006047 |
| T6 | 813-818 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T7 | 1560-1565 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 73-90 | Phenotype | denotes | pancreatic cancer | HP:0002894 |
| T2 | 139-144 | Phenotype | denotes | tumor | HP:0002664 |
| T3 | 171-176 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 405-430 | Phenotype | denotes | pancreatic adenocarcinoma | HP:0006725 |
| T5 | 813-818 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 1560-1565 | Phenotype | denotes | tumor | HP:0002664 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 14-20 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T2 | 478-484 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T3 | 531-537 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
| T4 | 1080-1094 | Glycan | denotes | sialyl Lewis x | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO |
| T5 | 1420-1426 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 772-776 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | CC49 | http://www.glycoepitope.jp/epitopes/AN0086 |
| T2 | 911-915 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | CC49 | http://www.glycoepitope.jp/epitopes/AN0086 |
| T3 | 1080-1094 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | sialyl Lewis x | http://www.glycoepitope.jp/epitopes/EP0012 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 73-90 | Phenotype | denotes | pancreatic cancer | HP:0002894 |
| T2 | 139-144 | Phenotype | denotes | tumor | HP:0002664 |
| T3 | 171-176 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 405-430 | Phenotype | denotes | pancreatic adenocarcinoma | HP:0006725 |
| T5 | 813-818 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 1560-1565 | Phenotype | denotes | tumor | HP:0002664 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 84-95 | Cell | denotes | cancer cell | http://purl.obolibrary.org/obo/CL:0001064 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 73-90 | Disease | denotes | pancreatic cancer | MONDO:0005192|MONDO:0009831 |
| T3 | 139-144 | Disease | denotes | tumor | MONDO:0005070 |
| T4 | 171-176 | Disease | denotes | tumor | MONDO:0005070 |
| T5 | 405-430 | Disease | denotes | pancreatic adenocarcinoma | MONDO:0006047 |
| T6 | 813-818 | Disease | denotes | tumor | MONDO:0005070 |
| T7 | 1560-1565 | Disease | denotes | tumor | MONDO:0005070 |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 772-776 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | CC49 | http://www.glycoepitope.jp/epitopes/AN0086 |
| T2 | 911-915 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | CC49 | http://www.glycoepitope.jp/epitopes/AN0086 |
| T3 | 1080-1094 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | sialyl Lewis x | http://www.glycoepitope.jp/epitopes/EP0012 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 67-72 | Organism | denotes | human | 9606 |
| T2 | 399-404 | Organism | denotes | human | 9606 |
| T3 | 646-651 | Organism | denotes | human | 9606 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-165 | Sentence | denotes | Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. |
| T2 | 166-342 | Sentence | denotes | Many tumor-associated epitopes possess carbohydrate as a key component, and thus changes in the activity of glycosyltransferases could play a role in generating these epitopes. |
| T3 | 343-576 | Sentence | denotes | In this report we describe the stable transfection of a human pancreatic adenocarcinoma cell line, Panc1-MUC1, with the cDNA for mucin core 2 GlcNAc-transferase (C2GnT), which creates the core 2 beta-1,6 branch in mucin-type glycans. |
| T4 | 577-662 | Sentence | denotes | These cells lack endogenous C2GnT activity but express a recombinant human MUC1 cDNA. |
| T5 | 663-839 | Sentence | denotes | C2GnT-transfected clones expressing different levels of C2GnT were characterized using monoclonal antibodies CC49, CSLEX-1, and SM-3, which recognize tumor-associated epitopes. |
| T6 | 840-1017 | Sentence | denotes | Increased C2GnT expression led to greatly diminished expression of the CC49 epitope, which we identified as NeuAcalpha2,6(Galbeta1,3)GalNAcalpha-Ser/Thr in the Panc1-MUC1 cells. |
| T7 | 1018-1172 | Sentence | denotes | This was accompanied by the emergence of the CSLEX-1 epitope, sialyl Lewis x (NeuAcalpha2,3Galbeta1,4(Fucalpha1,3)GlcNAc-R), an important selectin ligand. |
| T8 | 1173-1248 | Sentence | denotes | Despite this, however, the C2GnT transfectants could not bind to selectins. |
| T9 | 1249-1456 | Sentence | denotes | Increased C2GnT expression also led to masking of the SM-3 peptide epitope, which persisted after the removal of sialic acid, further suggesting greater complexity of the core 2-associated O-glycans on MUC1. |
| T10 | 1457-1586 | Sentence | denotes | The results of this study suggest that C2GnT could play a regulatory role in the expression of certain tumor-associated epitopes. |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 67-72 | OrganismTaxon | denotes | human | 9606 |
| T2 | 399-404 | OrganismTaxon | denotes | human | 9606 |
| T3 | 646-651 | OrganismTaxon | denotes | human | 9606 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 84-95 | Cell | denotes | cancer cell | http://purl.obolibrary.org/obo/CL:0001064 |